Search Constraints
« Previous |
41 - 60 of 76
|
Next »
Search Results
Select an image to start the slideshow
A medicinal chemistry approach towards brodomain epigenetic modulators
1 of 20
Synthesis and optimisation of novel molecules to probe epigenetic mechanisms with applications in the treatment of inflammatory disorders
2 of 20
Novel C-C bond formation strategies for access to secondary and tertiary amides enabled by new synthetic technologies
3 of 20
Studies towards the synthesis and labelling of bioactive peptides
4 of 20
Novel approaches targeting phosphoinositide 3-kinase delta
5 of 20
Iron-catalysed cross-couplings of secondary alkyl Grignard reagents
6 of 20
Increasing the saturation of BET inhibitors
7 of 20
Mechanistic pharmacokinetic / pharmacodynamic modelling of acute inflammatory challenge models
8 of 20
Investigating and exploiting best practices in hit identification and hit to lead chemistry
9 of 20
Chan-Lam animation studies : solving the chemotype reactivity issue
10 of 20
Development of lysine acylating small molecules for covalent kinase inhibition
11 of 20
The development of small molecule inhibitors for fibrosis drug discovery
12 of 20
Novel biocatalytic strategies for the synthesis of N-functionalised amino acids
13 of 20
Synthesis of non-natural base-pairs : towards site-specific functionalisation of nucleic acids
14 of 20
New methods for the construction of selectively difluorinated carbocycles
15 of 20
Computational modelling of enzyme activity to speed up biocatalyst redesign
16 of 20
Single electron transfer in organic synthesis targeted towards sustainable manufacture
17 of 20
Utilisation of rearrangement chemistry in the synthesis of novel fluorinated ring systems : a computational and experimental study
18 of 20
The interplay of multiple ADME mechanisms : prediction of hepatic drug-drug interactions from in vitro
19 of 20
Early application of mechanistic PKPD modelling to guide the preclinical development of a therapeutic mAb targeting complement receptor 2 (CR2/CD21) as a novel target for the treatment of autoimmune disease
20 of 20